Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$35,643,044
+$4,812,750 QoQ
Shares Held
141,643
-0.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
2.73%
of 13F equity value
Holder Rank
#441
of 4,152 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KANAWHA CAPITAL MANAGEMENT LLC holds $95,466,643 across 8 Drug Manufacturers - General names. ABBV ranks #2 (37.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
148,501 | $37,714,798 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
141,643 | $35,643,044 | |
| 3 | LLY |
ELI LILLY & Co
|
8,046 | $9,650,614 | |
| 4 | PFE |
Pfizer Inc
|
290,647 | $6,998,779 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
40,741 | $2,347,496 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,938 | $1,662,533 | |
| 7 | AMGN |
Amgen Inc
|
2,441 | $883,934 | |
| 8 | NVS |
Novartis AG
|
3,608 | $565,445 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,643,044 | 141,643 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $30,830,294 | 141,755 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $32,463,859 | 142,080 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $33,134,531 | 143,105 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $26,816,521 | 144,470 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $30,171,927 | 144,005 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $25,607,458 | 144,105 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $28,127,471 | 142,432 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $25,530,065 | 148,846 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $25,880,416 | 142,122 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $21,959,249 | 141,700 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $22,454,249 | 150,639 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $20,456,190 | 151,831 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $24,245,117 | 152,131 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $24,539,024 | 151,841 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $20,435,888 | 152,268 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $23,563,359 | 153,848 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $25,219,939 | 155,573 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $21,031,140 | 155,326 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $17,101,062 | 158,534 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $17,921,587 | 159,105 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $17,247,778 | 159,377 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $17,338,798 | 161,818 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $14,089,552 | 160,858 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $15,781,158 | 160,737 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $12,171,581 | 159,753 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||